The GALT chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GALT chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The GALT stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View GALT Detailed Price Forecast - CNN Money||View GALT Detailed Summary - Google Finance|
|View GALT Detailed Summary - Yahoo! Finance||View GALT Stock Research & Analysis - Zacks.com|
|View GALT Trends & Analysis - Trade-Ideas||View GALT Major Holders - Barrons|
|View GALT Call Transcripts - NASDAQ||View GALT Breaking News & Analysis - Seeking Alpha|
|View GALT Annual Report - CompanySpotlight.com||View GALT OTC Short Report - OTCShortReport.com|
|View GALT Fundamentals - TradeKing||View GALT SEC Filings - Bar Chart|
|View Historical Prices for GALT - The WSJ||View Performance/Total Return for GALT - Morningstar|
|View the Analyst Estimates for GALT - MarketWatch||View the Earnings History for GALT - CNBC|
|View the GALT Earnings - StockMarketWatch||View GALT Buy or Sell Recommendations - MacroAxis|
|View the GALT Bullish Patterns - American Bulls||View GALT Short Pain Metrics - ShortPainBot.com|
|View GALT Stock Mentions - StockTwits||View GALT Stock Mentions - PennyStockTweets|
|View GALT Stock Mentions - Twitter||View GALT Investment Forum News - Investor Hub|
|View GALT Stock Mentions - Yahoo! Message Board||View GALT Stock Mentions - Seeking Alpha|
|View Insider Transactions for GALT - SECform4.com||View Insider Transactions for GALT - Insider Cow|
|View GALT Major Holdings Summary - CNBC||View Insider Disclosure for GALT - OTC Markets|
|View Insider Transactions for GALT - Yahoo! Finance||View Institutional Holdings for GALT - NASDAQ|
|View GALT Stock Insight & Charts - FinViz.com||View GALT Investment Charts - StockCharts.com|
|View GALT Stock Overview & Charts - BarChart||View GALT User Generated Charts - Trading View|
Recent Analysis Shows Alphabet, Northrop Grumman, HomeStreet, Galectin Therapeutics, AZZ, and Restoration Robotics Market Influences — Renewed Outlook, Key Drivers of Growth
Posted on Thursday April 26, 2018
NEW YORK, April 26, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
LONDON, UK / ACCESSWIRE / April 23, 2018 / Active-Investors.com has just released a free research report on Adamas Pharma, Inc. (NASDAQ: ADMS). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=ADMS as the Company's latest news hit the wire. On April 18, 2018, the Company announced positive data from the completed Phase-3 open-label trial, EASE LID 2, assessing GOCOVRI™ (amantadine) extended release capsules for the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications.
Galectin Therapeutics to Present at 2nd Annual NASH Summit 2018
Posted on Wednesday April 18, 2018
NORCROSS, Ga., April 18, 2018-- Galectin Therapeutics Inc., the leading developer of therapeutics that target galectin proteins, today announced that Peter G. Traber, M.D., the Company’ s CEO and CMO, ...
Galectin Therapeutics Late-Breaker Presentation at The International Liver Congress Reinforces and Extends the Positive Effects of GR-MD-02 in Patients With NASH Cirrhosis
Posted on Monday April 16, 2018
NORCROSS, Ga., April 16, 2018-- Galectin Therapeutics Inc., the leading developer of therapeutics that target galectin proteins, today provided highlights from a late-breaker oral presentation at The International ...